Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0
ClinicalTrialUtilities: обзор

Галерея

Chapter 6 - Veterinary Medicine
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Medication Health Fraud
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Patent Certifications and Suitability Petitions
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Bryant Ranch Prepack Inc. Issues Voluntary Nationwide Recall of Morphine Sulfate 30 mg Extended Release and Morphine Sulfate 60 mg Extended-Release Due to Label-Mix Up
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask - 06/30/2022
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
What's New Related to Drugs
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Condition-Specific Meeting Reports and Other Information Related to Patients' Experience
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Biologics PREA Reviews and Labeling Changes
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-06-29 By FDA
Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Guidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
Source: FDA - What's New: Drugs RSS Feed Published on 2022-06-29 By FDA
Vaccines Protect Children From Harmful Infectious Diseases
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-06-29 By FDA
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Obesity;Overweight, Date of authorisation: 23/03/2015, Revision: 12, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29
Human medicines European public assessment report (EPAR): HBVaxPro, hepatitis B vaccine (recombinant DNA), Hepatitis B;Immunization, Date of authorisation: 27/04/2001, Revision: 30, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29
Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Immunization;Rotavirus Infections, Date of authorisation: 21/02/2006, Revision: 40, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-06-29

Предыдущие записи

Тема: Scaffold от Danny Cooper.